Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (<i>CloroCovid-19 Study</i>)

Mayla Gabriela Silva Borba; Fernando de Almeida Val; Vanderson Souza Sampaio; Marcia Araujo Alexandre; Gisely Cardoso Melo; Marcelo Brito; Maria Mourao; Jose Diego Brito Sousa; djane Baia-da-Silva; Marcus Vinitius Farias Guerra; Ludhmila Abrahāo Hajjar; Rosemary Costa Pinto; Antonio Alcirley Silva Balieiro; Felipe Gomes Naveca; Mariana Simāo Xavier; Alexandre Salomao; André Machado Siqueira; Alexandre Schwarzbolt; Julio Henrique Rosa Croda; Mauricio Lacerda Nogueira; Gustavo Adolfo Sierra Romero; Quique Bassat; Cor Jesus Fontes; Bernardino Cláudio Albuquerque; Cláudio Tadeu Daniel-Ribeiro; Wuelton Marcelo Monteiro; Marcus Vinícus Guimarães Lacerda

Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)

bioRxiv (2020) - Comments
doi: 10.1101/2020.04.07.20056424

Mayla Gabriela Silva Borba, Fernando De Almeida Val, Vanderson Souza Sampaio, Marcia Araujo Alexandre, Gisely Cardoso Melo, Marcelo Brito, Maria Mourao, Jose Diego Brito Sousa, Djane Baia-da-Silva, Marcus Vinitius Farias Guerra, Ludhmila Abrahāo Hajjar, Rosemary Costa Pinto, Antonio Alcirley Silva Balieiro, Felipe Gomes Naveca, Mariana Simāo Xavier, Alexandre Salomao, André Machado Siqueira, Alexandre Schwarzbolt, Julio Henrique Rosa Croda, Mauricio Lacerda Nogueira